141
Views
45
CrossRef citations to date
0
Altmetric
Review

Collateral therapeutics for cerebral ischemia

Pages 255-265 | Published online: 10 Jan 2014

References

  • Leary MC, Saver JL. Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc. Dis. 16(3), 280–285 (2003).
  • Liebeskind DS, Messe SR, Luciano JM, Kasner SE. A novel CT angiography scale for assessment of collaterals in acute stroke. Stroke 34(1), 265 (2003).
  • Liebeskind DS, Kasner SE. Neuroprotection for ischemic stroke: an unattainable goal? CNS Drugs 15 (3), 165–174 (2001).
  • Wahlgren NG, Ahmed N. Neuroprotection in cerebral ischemia: facts and fancies — the need for new approaches. Cerebrovasc. Dir. 17\(Suppl. 1) 153–166 (2004).
  • Kaste M. Thrombolysis in ischaemic stroke — present and future: role of combined therapy. Cerebrovasc. Dis. 11 (Suppl. 1) 55–59 (2001).
  • Vernieri F, Tibuzzi F, Pasqualetti P et al. Transcranial doppler and near-infrared spectroscopy can evaluate the hemodynamic effect of carotid artery occlusion. Stroke 35(1), 64–70 (2004).
  • Reinhard M, Muller T, Guschlbauer B, Timmer J, Hetzel A. Dynamic cerebral autoregulation and collateral flow patterns in patients with severe carotid stenosis or occlusion. Ultrasouncl Merl Biol. 29(8), 1105–1113 (2003).
  • Hoksbergen AW, Legemate DA, Csiba L et al Absent collateral function of the circle of Willis as risk factor for ischemic stroke. Cerebrovasc. Dis. 16(3), 191–198 (2003).
  • Bisschops RH, Klijn CJ, Kappelle LJ, van Huffelen AC, van der Grond J. Collateral flow and ischemic brain lesions in patients with unilateral carotid artery occlusion. Neurology 60(9), 1435–1441 (2003).
  • Schellinger PD, Fiebach JB, Hacke W Imaging-based decision making in thrombolytic therapy for ischemic stroke: present status. Stroke 34(2), 575–583 (2003).
  • Kucinski T, Koch C, Eckert B et al. Collateral circulation is an independent radiological predictor of outcome after thrombolysis in acute ischaemic stroke. Neuroradiology45(1), 11–18 (2003).
  • •Interesting analysis of thrombolytic outcome demonstrating the influential role of the collateral circulation.
  • Roberts HC, Dillon WP, Furlan AJ et al. Computed tomographic findings in patients undergoing intra-arterial thrombolysis for acute ischemic stroke due to middle cerebral artery occlusion: results from the PROACT II trial. Stroke 33(6), 1557–1565 (2002).
  • Higashida RT, Furlan AJ, Roberts H et al Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 34(8), 109–137 (2003).
  • Lansberg MG, Tong DC, Norbash AM, Yenari MA, Moseley ME. Intra-arterial rtPA treatment of stroke assessed by diffusion- and perfusion-weighted MR.I. Stroke 30(3), 678–680 (1999).
  • Maeda M, Yamamoto T, Daimon S, Sakuma H, Takeda K. Arterial hyperintensity on fast fluid-attenuated inversion recovery images: a subtle finding for hyperacute stroke undetected by diffusion-weighted MR imaging. AJNR Am. Neumracliol 22(4), 632–636 (2001).
  • Rother J, Schellinger PD, Gass A et al Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke 6 h. Stroke 33(10), 2438–2445 (2002).
  • Schlaug G, Benneld A, Baird AE et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI. Neumlogy 53(7), 1528–1537 (1999).
  • Liebeskind DS, Ances BM, Weigele JB, Hurst RVV. Intravascular deoxygenation of leptomeningeal collaterals detected with gradient echo MRI. Stroke 35(1), 266 (2004).
  • Diez-Tejedor E, Fuentes B. Acute care in stroke: the importance of early intervention to achieve better brain protection. Cerebnwasc. Dis. 17\(Suppl. 1), 130–137 (2004).
  • Liebeskind DS. Collateral circulation. Stroke 34(9), 2279–2284 (2003).
  • ••Recent overview of the collateralcirculation.
  • Van Lieshout JJ, Wieling W Karemaker JM, Secher NH. Syncope, cerebral perfusion and oxygenation. I Appl. Physiol 94(3), 833–848 (2003).
  • Wojner AW, El-Mitwalli A, Alexandrov AV. Effect of head positioning on intracranial blood flow velocities in acute ischemic stroke: a pilot study. Grit. Care Nurs. Q 24(4), 57–66 (2002).
  • Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke. Stroke 33 (2), 497–501 (2002) .
  • •Excellent paper discussing the effect of head positioning on cerebral perfusion.
  • Kraus JJ, Metzler MD, Coplin WM. Critical care issues in stroke and subarachnoid hemorrhage. Neural. Res. 24\(Suppl. 1), S47—S57 (2002).
  • Asplund K. Haemodilution for acute ischaemic stroke. Cochrane Database Syst. Rev (4), CD000103 (2002).
  • Christensen H. Hypertension in acute stroke. Arrh. Intern. Med 163(21), 2651–2652 (2003).
  • Semplicini A, Maresca A, Boscolo G et al Hypertension in acute ischemic stroke: a compensatory mechanism or an additional damaging factor? Arch. Intern. Med. 163(2), 211–216 (2003).
  • Bhalla A, Tilling K, Kolominsky-Rabas P et al Variation in the management of acute physiological parameters after ischaemic stroke: a European perspective. Eur. Neural. 10(1), 25–33 (2003).
  • Alexandrov AV, Felberg RA, Demchuk AM et al Deterioration following spontaneous improvement : sonographic findings in patients with acutely resolving symptoms of cerebral ischemia. Stroke 31(4), 915–919 (2000).
  • Toni D, Fiorelli M, Bastianello S et al Acute ischemic strokes improving during the first 48 h of onset: predictability, outcome and possible mechanisms. A comparison with early deteriorating strokes. Stroke28(1), 10–14 (1997).
  • •Important paper on early fluctuations in the neurological status of acute ischemic stroke patients.
  • Sumer M, Ozdemir I, Erturk O. Progression in acute ischemic stroke: frequency, risk factors and prognosis. Clin. Neurosci. 10(2), 177–180 (2003).
  • Arenillas JF, Rovira A, Molina CA et al Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke. Stroke 33(9), 2197–2203 (2002).
  • Christensen H, Boysen G, Johannesen III I, Christensen E, Bendtzen K. Deteriorating ischaemic stroke. cytokines, soluble cytokine receptors, ferritin, systemic blood pressure, body temperature, blood glucose, diabetes, stroke severity and CT infarction-volume as predictors of deteriorating ischaemic stroke. .j Neural. Sci. 201(1–2), 1–7 (2002).
  • Hart GB, Strauss MB. Hyperbaric oxygen therapy. Stroke 34(9), 153–155 (2003).
  • Jain KIK. Hyperbaric oxygen in acute ischemic stroke. Stroke 34(9), 153 (2003).
  • Zhang JH, Singhal AB, Toole JF. Oxygen therapy in ischemic stroke. Stroke 34(9), 152–153 (2003).
  • •Important commentary on the role of oxygen therapy for ischemic stroke.
  • Rusyniak DE, Kirk MA, May JD et al Hyperbaric oxygen therapy in acute ischemic stroke: results of the Hyperbaric Oxygen in Acute Ischemic Stroke Trial Pilot Study. Stmke34(2), 571–574 (2003).
  • Milik0ViC-LOBC M, Silbergleit R, Fiskum G, Rosenthal RE. Neuroprotective effects of hyperbaric oxygen treatment in experimental focal cerebral ischemia are associated with reduced brain leukocyte myeloperoxidase activity. Brain Res. 971(1), 90–94 (2003).
  • Rogatsky GG, Shifrin EG, Mayevsky A. Optimal dosing as a necessary condition for the efficacy of hyperbaric oxygen therapy in acute ischemic stroke: a critical review. Neural. Res. 25(1), 95–98 (2003).
  • Sunami K, Takeda Y, Hashimoto M, Hirakawa M. Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery. Grit. Cam Med. 28(8), 2831–2836 (2000).
  • Veltkamp R, Warner DS, Domoki F et al Hyperbaric oxygen decreases infarct size and behavioral deficit after transient focal cerebral ischemia in rats. Brain Res. 853(1), 68–73 (2000).
  • Flynn EP, Auer RN. Eubaric hyperoxemia and experimental cerebral infarction. Ann. Neural 52(5), 566–572 (2002).
  • Singhal AB, Dijkhuizen RIVI, Rosen BR, Lo EH. Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology58 (6), 945–952 (2002).
  • Caviness VS, Makris N, Montinaro E et al. Anatomy of stroke. Part I: an MRI-based topographic and volumetric system of analysis. Stroke 33(11), 2549–2556 (2002).
  • Harrigan MR. Angiogenic factors in the central nervous system. Neurosurgery53(3), 639–660 (2003).
  • Zadeh G, Guha A. Angiogenesis in nervous system disorders. Neumsurgery53(6), 1362–1374 (2003).
  • Zhang Z, Chopp M. Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. Trends Camliovasc. Med. 12(2), 62–66 (2002).
  • Croll SD, Wiegand SJ. Vascular growth factors in cerebral ischemia. Mal. Neurobial 23(2-3), 121–135 (2001).
  • Scholz D, Cai WJ, Schaper W Arteriogenesis, a new concept of vascular adaptation in occlusive disease. Angiogenesis 4(4), 247–257 (2001).
  • ••Excellent discussion of arteriogenesis.
  • Helisch A, Schaper W Arteriogenesis: the development and growth of collateral arteries. Mcmchrulation10(1), 83–97 (2003).
  • ••Superb overview of arteriogenesis.
  • Buschmann IR, Busch HJ, Mies G, Hossmann IKA. Therapeutic induction of arteriogenesis in hypoperfused rat brain via granulocyte-macrophage colony-stimulating factor. Cunt/at/on 108(5), 610–615 (2003).
  • •Landmark paper on the first demonstration of therapeutic arteriogenesis for cerebral ischemia.
  • Liebeskind DS. Anatomic considerations in therapeutic arteriogenesis for cerebral ischemia. Circulation 109 (2), (2004) .
  • Tsai TH, Chen SL, Xiao X et al. Gene treatment of cerebral stroke by rAAV vector delivering IL- lra in a rat model. Neumreport 14(6), 803–807 (2003).
  • Yenari MA, Zhao H, Giffard RG. et al Gene therapy and hypothermia for stroke treatment. Ann. NY Acad. Sc]. 993,54–68 (2003).
  • Saitoh Y, Kato A, Hagihara Y, Kaneda Y, Yoshimine T Gene therapy for ischemic brain diseases. CUI7: Gene Ther 3(1), 49–58 (2003).
  • Masumu M, Hata R. Recent advances in adenovirus-mediated gene therapy for cerebral ischemia. CUI7: Gene Ther 3(1), 43–48 (2003).
  • Ooboshi H, Ibayashi S, Takada J, Kumai Y, Iida M. Brain ischemia as a potential target of gene therapy. Exp. Gerontal 38(1–2), 183–187 (2003).
  • Tsai TH, Chen SL, Xiao X, Liu DW, Tsao YR Gene therapy for treatment of cerebral ischemia using defective recombinant adeno-associated virus vectors. Methods 28(2), 253–258 (2002).
  • Zhang ZG, Zhang L, Croll SD, Chopp M. Angiopoietin-1 reduces cerebral blood vessel leakage and ischemic lesion volume after focal cerebral embolic ischemia in mice. Neuroscience 113(3), 683–687 (2002).
  • Yoshimura S, Morishita R, Hayashi K et al. Gene transfer of hepatocyte growth factor to subarachnoid space in cerebral hypoperfusion model. Hypertension 39(5), 1028–1034 (2002).
  • Wada K, Sugimori H, Bhide PG, Moskowitz MA, Finklestein SP. Effect of basic fibroblast growth factor treatment on brain progenitor cells after permanent focal ischemia in rats. Stroke 34(11), 2722–2728 (2003).
  • Pichiule P, Agani F, Chavez JC, Xu K, LaManna JC. HIP-1 a and VEGF expression after transient global cerebral ischemia. Adv. Exp. Med. Biol. 530611–617 (2003).
  • Mackay KB, Loddick SA, Naeve GS et al. Neuroprotective effects of insulin-like growth factor-binding protein ligand inhibitors in vitro and in vivo. j Cereb. Blood Flow Metab. 23(10), 1160–1167 (2003).
  • Hai J, Li ST, Lin Q et al Vascular endothelial growth factor expression and angiogenesis induced by chronic cerebral hypoperfusion in rat brain. Neurosurgery 53(4), 963–970 (2003).
  • Sun Y, Jin K, Xie L et al VEGF-induced neuroprotection, neurogenesis and angiogenesis after focal cerebral ischemia. Clin. Invest. 111(12), 1843–1851 (2003).
  • Ellsworth JL, Garcia R, Yu J, Kindy MS. Fibroblast growth factor-18 reduced infarct volumes and behavioral deficits after transient occlusion of the middle cerebral artery in rats. Stroke 34(6), 1507–1512 (2003).
  • Chen J, Zhang ZG, Li Y et al Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Chr. Res. 92(6), 692–699 (2003).
  • Harrigan MR, Ennis SR, Sullivan SE, Keep RE Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, oedema and infarct volume. Acta Neurochir. 145(1), 49–53 (2003).
  • Scheufler KM, Drevs J, van Velthoven V et al Implications of vascular endothelial growth factor, sFlt-1 and sTie-2 in plasma, serum and cerebrospinal fluid during cerebral ischemia in man. j Cereb. Blood Flow Metah 23(1), 99–110 (2003).
  • El-Koussy M, Lovblad KO, Kiefer C et al Apparent diffusion coefficient mapping of infarcted tissue and the ischaemic penumbra in acute stroke. Neuroradiology 44(10), 812–818 (2002).
  • Tamura H, Hatazawa J, Toyoshima H, Shimosegawa E, Okudera T Detection of deoxygenation-related signal change in acute ischemic stroke patients by T2-weighted magnetic resonance imaging. Stroke 33 (4), 967–971 (2002) .
  • Krakow K, Ries S, Daffertshofer M, Hennerici M. Simultaneous assessment of brain tissue oxygenation and cerebral perfusion during orthostatic stress. Eur Neural 43(1), 39–46 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.